Understanding Balo's Concentric Sclerosis

Finding out you have Balo’s Concentric Sclerosis (BCS) can be a frightening experience, especially if you have searched for information online. Many older medical resources describe BCS as a “uniformly fatal” condition—a terrifying phrase for any patient to read. However, it is vital to know that this view is outdated. It was based on a time before modern imaging, when the disease was usually only discovered during an autopsy of the most severe cases ^[1][2].

In the modern era of Magnetic Resonance Imaging (MRI), doctors can identify BCS early and begin treatment immediately. We now know that many people survive BCS, and many go on to have a high quality of life with manageable levels of disability, depending heavily on the location and severity of the initial attack ^[3][4].

Understanding the “Onion Skin” Pattern

BCS is a rare inflammatory disease of the Central Nervous System (CNS), which includes your brain and spinal cord. It is a demyelinating disease, meaning the body’s immune system mistakenly attacks myelin, the protective fatty coating that insulates your nerve fibers ^[1].

What makes BCS unique is the way it looks on an MRI. While typical Multiple Sclerosis (MS) often creates solid “spots” or plaques, BCS creates lesions that look like a bullseye or the layers of an onion. This happens because of a specific biological pattern:

• Alternating Rings: The “rings” are made of layers where myelin has been stripped away (demyelination) next to layers where the myelin is still relatively intact or preserved ^[5][1].
• The “Frontier” of Injury: The disease often starts at a center point and expands outward. At the leading edge, cells called oligodendrocytes (which make and maintain myelin) are injured or destroyed ^[5][6].
• The Hypoxia Hypothesis: Some researchers propose that low oxygen levels (hypoxia) in the brain tissue may play a role in how these rings form, possibly creating stress zones that the immune system then attacks, though this remains an unproven hypothesis ^[7][8].

How Rare is BCS?

BCS is exceptionally rare. Because it is so uncommon, it is difficult for scientists to pin down an exact incidence rate for the general population. In one specific large study of 2,600 patients with MS-like conditions, only 10 individuals—less than 0.4% of that selected cohort—were found to have BCS ^[9]. Most neurologists see very few cases in their entire career, which is why your care is often guided by a neuroimmunologist.

Is it Multiple Sclerosis or Something Else?

There is a long-standing debate in the medical community about whether BCS is a specific, aggressive variant of Multiple Sclerosis (MS) or its own distinct disease ^[2].

• The MS Connection: Many patients with BCS also have “typical” MS lesions elsewhere in their brain. Furthermore, when doctors look at the tissue under a microscope, the inflammation often looks identical to what is seen in certain types of MS ^[2][8].
• The Distinction: On the other hand, in one large analysis, BCS patients often lacked oligoclonal bands (specific proteins in the spinal fluid) that are found in about 95% of MS patients ^[10]. While the absence of these bands may help differentiate BCS from typical MS in a clinic, it is important to remember that antibody and spinal-fluid results do not confirm or rule out BCS by themselves.

Looking Ahead: Survival and Recovery

The shift in how we view BCS is profound. While 10% of cases in a 40-case cohort study were fatal during the initial attack, the majority of patients now survive ^[2].

One of the most encouraging statistics for newly diagnosed patients is that BCS is often monophasic. This means that in that same cohort, about 56% of patients had a single one-time attack that did not return during follow-up ^[2].

Even for those who do experience relapses or have a more chronic course similar to MS, modern treatments—including high-dose steroids and advanced immunosuppressive therapies—can help manage the inflammation and protect the brain from further injury ^[4][11]. Your medical team will use regular MRIs to monitor for any “radial expansion” (outward growth) of the lesions and adjust your care accordingly ^[2][12].